key: cord-0753367-zn4urrxc
authors: Chi, Qiong; Dai, Xinjian; Jiang, Xiangao; Zhu, Lefei; Du, Junyan; Chen, Yuxi; Zheng, Jiyang; Huang, Jianping
title: Differential diagnosis for suspected cases of coronavirus disease 2019: a retrospective study
date: 2020-09-18
journal: BMC Infect Dis
DOI: 10.1186/s12879-020-05383-y
sha: 75c65c5a1d84091484f86c88a855d2c48b2d9eed
doc_id: 753367
cord_uid: zn4urrxc

BACKGROUND: Since December 2019, the coronavirus disease 2019 (COVID-19) has infected more than 12,322,000 people and killed over 556,000 people worldwide. However, Differential diagnosis remains difficult for suspected cases of COVID-19 and need to be improved to reduce misdiagnosis. METHODS: Sixty-eight cases of suspected COVID-19 treated in Wenzhou Central Hospital from January 21 to February 20, 2020 were divided into confirmed and COVID-19-negative groups based on the results of real-time reverse transcriptase polymerase chain reaction (RT-PCR) nucleic acid testing of the novel coronavirus in throat swab specimens to compare the clinical symptoms and laboratory and imaging results between the groups. RESULTS: Among suspected patients, 17 were confirmed to COVID-19-positive group and 51 were distinguished to COVID-19-negative group. Patients with reduced white blood cell (WBC) count were more common in the COVID-19-positive group than in the COVID-19-negative group (29.4% vs 3.9%, P = 0.003). Subsequently, correlation analysis indicated that there was a significant inverse correlation existed between WBC count and temperature in the COVID-19-positive patients (r = − 0.587, P = 0.003), instead of the COVID-19-negative group. But reduced lymphocyte count was no different between the two groups (47.1% vs 25.5%, P = 0.096). More common chest imaging characteristics of the confirmed COVID-19 cases by high-resolution computed tomography (HRCT) included ground-glass opacities (GGOs), multiple patchy shadows, and consolidation with bilateral involvement than COVID-19-negative group (82.4% vs 31.4%, P = 0.0002; 41.2% vs 17.6% vs P = 0.048; 76.5% vs 43.1%, P = 0.017; respectively). The rate of clustered infection was higher in COVID-19-positive group than COVID-19-negative group (64.7% vs 7.8%, P = 0.001). Through multiplex PCR nucleic acid testing, 2 cases of influenza A, 3 cases of influenza B, 2 cases of adenovirus, 2 cases of Chlamydia pneumonia, and 7 cases of Mycoplasma pneumoniae were diagnosed in the COVID-19-negative group. CONCLUSIONS: WBC count inversely correlated with the severity of fever, GGOs, multiple patchy shadows, and consolidation in chest HRCT and clustered infection are common but not specific features in the confirmed COVID-19 group. Multiplex PCR nucleic acid testing helped differential diagnosis for suspected COVID-19 cases.

Since December 2019, the epidemic of pneumonia caused by novel coronavirus in China, has continued to progress [1] , having now infected more than 12,322,000 people and killed over 556,000 people worldwide [2] . On February 11, 2020, The International Committee on Taxonomy of Viruses officially named this severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the World Health Organization (WHO) named the disease coronavirus disease 2019 (COVID-19) [3] . Phylogenetic analysis revealed that SARS-CoV-2 falls into the genus betacoronavirus, which includes coronaviruses (SARS-CoV, bat SARS-like CoV, and others) discovered in humans, bats, and other wild animals [4] . On March 11, 2020 , the WHO also designated COVID-19 a pandemic [2] . According to epidemiological investigations, the general population is susceptible to SARS-CoV-2, which has the possible route of transmission via droplets, fecal matter, and contact [5] . Because symptoms overlap significantly with other respiratory infections like influenza, diagnosis remains difficult.

Wenzhou had hundreds of confirmed imported cases of COVID-19 and even more suspected cases. Measures to more rapidly and accurately diagnose suspected cases of COVID-19 are challenges that urgently need to be addressed by clinicians. We therefore conducted this study to investigate the clinical characteristics of suspected cases of COVID-19 and to improve the differential diagnosis for COVID-19, thus reduce misdiagnosis.

We retrospectively collected the clinical data, including demographics, clinical manifestations, laboratory and radiological findings and contact history of suspected COVID-19 cases in isolation ward (single rooms) of Wenzhou Central Hospital from January 19, 2020 to February 20, 2020. The diagnostic criteria [6] of suspected cases were: individuals matching any one of the criteria for epidemiological history and any 2 of the clinical manifestations, or individuals matching any 3 of the clinical manifestations when there was no definitive epidemiological history. Epidemiological history included (1) history of travel or residence in Wuhan within 14 days before the disease onset; (2) history of contact with patients confirmed with COVID-19 within 14 days before the disease onset; (3) history of contact with individuals with respiratory symptoms who came from Wuhan or communities with reported COVID-19 cases within 14 days before the disease onset; and (4) clustered disease, meaning ≥2 cases with fever and/or respiratory symptoms. Clinical manifestations included (1) fever, (2) chest imaging showing multiple small patchy shadows and interstitial changes, particularly in the lung periphery, during the early stages, which progressed to multiple ground-glass opacities (GGOs), infiltrates, and consolidation; and (3) normal or reduced total white blood cell (WBC) count or reduced lymphocyte count in the early stages. Criteria to confirm or rule out the diagnosis of COVID-19 was as follows [6] : Confirmed COVID-19 cases: positive real-time reverse transcriptase polymerase chain reaction (RT-PCR) SARS-CoV-2 nucleic acid testing or viral gene sequencing showing high sequence homology to known gene sequences of SARS-CoV-2; COVID-19-negative cases: suspected cases with 2 consecutive negative results of respiratory pathogen nucleic acid testing (sampling time interval at least 1 day). In the same period, these samples were analyzed by multiplex PCR named GeXP assay (multiplex PCR combined with automated capillary electrophoresis) for 13 common respiratory pathogens including Influenza A (Flu A), Influenza B (Flu B), Influenza A H1N1 pdm09 (09H1), influenza H3N2 (H3), human para-influenza virus (HPIV), respiratory syncytial virus (RSV), rhinovirus (HRV), adenovirus (ADV), human metapneumovirus (HMPV), human bocavirus (HBoV), human coronavirus (HCoV), Chlamydia (Ch) and Mycoplasma pneumoniae (Mp) [7] .

Characteristics of patients were summarized using descriptive statistics. The continuous variables were presented as mean ± standard deviation (Mean ± SD), and the comparison between groups was analyzed by independent sample t-test. Categorical variables were expressed as the counts and percentages of patients in each category, and the group comparisons were performed using Chi-square test or Fisher's Exact test or Chi-square. P < 0.05 was considered statistically significant. The SPSS 22.0 software (IBM SPSS Inc., Chicago, IL) was used for statistical analysis in this study.

Sixty-eight suspected COVID-19 cases were recruited retrospectively to our study from January 21 to February 20, 2020. Among them, 17 were confirmed to be COVID-19 positive and 51 were COVID-19 negative. The clinical symptoms were no difference between two groups (Table 1) .

Laboratory tests, chest imaging, and nucleic acid testing are shown in Table 2 . Patients with reduced WBC count were more common in the confirmed COVID-19 group than in the COVID-19-negative group (29.4% vs 3.9%, P = 0.003). Subsequently, correlation analysis indicated that there was a significant inverse correlation existed between WBC count and temperature in the COVID-19-positive patients (r = − 0.587, P = 0.003), instead of the COVID-19-negative group (Fig. 1) . But reduced lymphocyte count was not found to be significantly different between the two groups (47.1% vs 25.5%, P = 0.096). More common chest imaging characteristics of the confirmed COVID-19 cases by high-resolution computed tomography (HRCT) included GGOs, multiple patchy shadows, and consolidation with bilateral involvement than COVID-19-negative group (82.4% vs 31.4%, P = 0.0002; 41.2% vs 17.6% vs P = 0.048; 76.5% vs 43.1%, P = 0.017; respectively). Bronchial wall thickening (9.8%) and reversed halo signs (2.0%) only saw in Chest HRCT of the COVID-19-negative group. 13 (76.5%) SARS-CoV-2 nucleic positive were identified in the first test of RT-PCR. 17.6% patients appeared negative results in the first round of test but turned to positive in the second round of test. Among the COVID-19-negative cases, 1 patient (2.0%) had a weakly positive result in the first viral nucleic acid test, but had negative results in the two following re-tests. Among the patients in the COVID-19-negative group, multiplex PCR testing showed 2 (3.9%) cases of influenza A with characteristic scattered and patchy shadows and nodular shadows in both lungs ( Fig. 3h & i) . No co-infections was observed in the COVID-19-positive or COVID-19-negative patients. The rate of clustered infection was higher in COVID-19-positive group than COVID-19-negative group (64.7% vs 7.8%, P = 0.001). The first familial cluster of COVID-19 involved transmission from a wife (who visited a physician due to 10 days of fever; she was confirmed to be SARS-CoV-2 positive in the second round of nucleic acid testing) to her husband (fatigue for a week and a day of fever; positive result on first SARS-CoV-2 nucleic acid test). Chest HRCTs showed a grid images in the inferior lobes of both lungs, especially obvious in the lung periphery ( Fig. 3a & b) . In the second cluster, the wife had a positive result in the first SARS-CoV-2 nucleic acid testing after 15 days of fever and her chest computed tomography (CT) showed multiple GGOs near the bilateral pleura. Her husband had a negative result in the first SARS-CoV-2 nucleic acid testing but a positive result upon the re-test on the first day of his fever and his chest CT showed a single GGO in the left lower lung near the pleura (Fig. 3c & d) . The third familial cluster involved transmission from husband (fever and cough for 13 days; positive result in the first SARS-CoV-2 nucleic acid testing) to his wife who remained asymptomatic (weak positive result in the first SARS-CoV-2 nucleic acid testing, and a positive result upon re-testing). The husband's chest CT showed multiple GGOs and consolidation near the pleura of the right lung, while the wife's chest CT showed patchy shadows near the pleura in the right lung ( Fig. 3e & f) . However, their son had no symptoms and normal WBC and lymphocyte counts with multiple GGOs and patchy shadows in his left lung (Fig. 3g) . After three negative viral nucleic testing of throat swabs or sputum, he was diagnosed COVID-19-negative. One familial cluster occurred in the COVID-19-negative group (father and son). Both were diagnosed with Mycoplasma pneumonia after multiplex PCR nucleic acid testing with hyperpyrexia and cough. There were two noninfectious cases in COVID-19negative group. One is 28-year-old previously healthy male patient who was diagnosed suspected case of COVID-19 due to cough, fever, increasing chest tightness gradually and GGOs and consolidation images in anterior basal segment of right lower lung of chest CT. Finally, Deep venous ultrasound showed right femoral vein thrombosis and computed tomography pulmonary angiogram (CTPA) showed multiple pulmonary embolisms in both lungs (Fig. 4a & b) . His medical history showed often long-term sedentary position in last 3 months for a test, and intermittent pain in his right lower extremity. The other suspected case had cough, (COVID-19) negative group. a Pneumonia caused by influenza A virus: scattered and patchy shadows and nodular shadows, with some of the nodular shadows surrounding the bronchovascular bundles; b pneumonia caused by influenza B virus: subpleural patchy shadows in the right lower lung; c pneumonia caused by adenovirus: consolidation near pleura of the right lower lung; and d Chlamydia pneumonia: multiple groundglass opacities (GGOs) and consolidations in both lungs fever, dyspnea and rashes symptoms with interstitial abnormalities in his both lungs (Fig. 4c & d) . This patient was eventually diagnosed as dermatomyositis with pulmonary involvement through testing of the spectrum of idiopathic inflammatory myopathies as.

As cases of COVID-19 increase in number worldwide, clinicians are struggling to diagnose new cases quickly enough to implement appropriate isolation measures. This is particularly difficult given how closely symptoms of COVID-19 match other common viral respiratory infections, including influenza. The aim of this study was to summarize the diagnostic features of suspected cases of COVID-19 in our hospital to help improve differential diagnosis, reduce misdiagnosis in future. Results of our study suggest that pneumonia in COVID-19 patients and pneumonia caused by other pathogens (eg, influenza viruses, adenovirus, and Mycoplasma) are difficult to distinguish based on their clinical manifestations, which included fever, cough, and fatigue in our study. Rarer clinical manifestations, such as expectoration, sore throat, intolerance of cold, shivering, chest tightness, dyspnea, palpitation, and diarrhea, were also common to both COVID-19 and other respiratory pathogens, which was similar to the results from previous studies [8, 9] .

Routine blood tests of COVID-19-positive patients showed that the WBC count was reduced, inversely correlating with the severity of fever, instead of COVID-19negative patients. This may contribute to the differential diagnosis of suspected cases. Approximately half (47.1%) of COVID-19-positive patients had reduced lymphocyte count; therefore, a reduced lymphocyte count in suspected cases of COVID-19 suggests the possibility of COVID-19. C-reactive protein of the COVID-19-positive patients was elevated, but was not significant for differential diagnosis. Most COVID-19-positive cases had bilateral pulmonary involvement with GGOs, multiple patchy shadows, and consolidation in their chest upon HRCT imaging, which may be helpful for differential diagnosis. However, these Chest HRCT imaging including patchy shadows, nodular shadows and grid-like also seen in the pneumonia caused by Influenza A virus, influenza B virus and adenovirus, consistent with the previous reports [10, 11] .

Clustered occurrence is one of the epidemiological criteria for the diagnosis of COVID-19 [12, 13] . Our study also shows 6 out of 17 cases were clustered, but clustering is not unique to COVID-19. Mycoplasma pneumonia can also occur in cluster with GGOs in chest CT. In this study, the 7 patients diagnosed with Mycoplasma pneumonia had a mean age of 29.5 years. Three of the patients were younger than 20 years old. Bronchial wall thickening, characteristic change of Mycoplasma pneumonia, in the chest HRCT of young adults may help distinguish Mycoplasma pneumonia from COVID-19.

Additionally, we recommend performing multiplex PCR nucleic acid testing using throat swabs or sputum. It should be noted that these results may be related to factors such as sampling quality, specimen preservation, and different nasopharyngeal virus concentrations at different stages of the disease [14] . Using multiplex PCR, we distinguish influenza A virus, influenza B virus, Adenovirus, Chlamydia pneumoniae, Mycoplasma pneumoniae and so on from suspected cases easily. In this study, no patient with COVID-19 was found coinfection with other respiratory pathogen(s). Recent report showed that rate of co-infection between SARS-CoV-2 and other respiratory pathogens reached 20.7% in northern California, USA. So, testing of SARS-CoV-2 should been done for patients with non-SARS-CoV-2 respiratory pathogens in high incidence of COVID-19 region [15] . The detection of non-SARS-CoV-2 respiratory pathogens by multiplex PCR may help to assess individual the risk of COVID-19 in areas of low transmission [16] . Because of the highly infectious nature of SARS-CoV2, the suspected COVID-19 cases were all isolated and monitored in a single-person single-room isolation ward. Although communication with healthcare professionals was limited, a detailed medical history should not be neglected. Therefore, it is important to remain open to all causes of lung pathology, including non-infectious causes like pulmonary embolism. For suspected COVID-19 cases, a comprehensive multidisciplinary collaborative diagnosis and treatment (MDT) mechanism should be established. Relevant departments including respiratory medicine, infectious diseases, and radiology should collaborate closely when COVID-19 is suspected to avoid misdiagnosis. Positive result of SARS-CoV-2 nucleic acid testing remains the gold standard for the diagnosis of COVID-19. However, highly suspicious cases with false negative viral nucleic acid testing results should have chest CT and consecutive viral nucleic acid testing in different specimens collected from multiple regions of the body (eg, sputum, throat swabs, blood, urine, and feces) [17] . These patients should also have the tests of serum SARS-CoV-2 specific-IgM and IgG antibodies [18] to improve the diagnosis rate.

This study has some limitations. Because COVID-19 was managed as Class A infectious disease, this study only performed routine blood tests, C-reactive protein, chest HRCT, throat swab SARS-CoV-2 nucleic acid testing, but not blood biochemical tests in the patients. As a result, we cannot comment on co-morbidities in our population. Additionally, the number of cases in this study was limited by the fact that COVID-19 is an emerging disease, and our findings need to be further verified by a large-scale study.

The clinical characteristics of patients with confirmed diagnosis of COVID-19 were similar to those negative cases. However, WBC count inversely correlated with the severity of fever, GGOs, multiple patchy shadows, and consolidation in chest HRCT and clustered infection are common but not specific features in the confirmed COVID-19 group. Multiplex PCR nucleic acid testing helped differential diagnosis for suspected COVID-19 cases. 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

WHO. Situation report -173: Coronavirus disease (COVID-2019

WHO. Situation report -22: Novel coronavirus (2019-nCoV

A novel coronavirus genome identified in a cluster of pneumonia cases -Wuhan

Clinical characteristics of coronavirus disease 2019 in China

National Health Commission of the People's Republic of China, Diagnosis and treatment program of the novel coronavirus pneumonia

A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study

Radiographic and CT features of viral pneumonia

RadioGraphics update: radiographic and CT features of viral pneumonia

A novel coronavirus from patients with pneumonia in China

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Thoughts on the name and clinical diagnosis of the respiratory tract infection caused by the novel coronavirus

Rates of co-infection between SARS-CoV-2 and other respiratory pathogens

Trend of respiratory pathogens during the COVID-19 epidemic

Zhejiang Da Xue Xue Bao Yi Xue Ban

Antibody detection and dynamic characteristics in patients with COVID-19

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

We would like to thank the medical staffs in the isolation ward of Wenzhou Central Hospital for their providing information about patients. We also thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.

Authors' contributions QC, JZ and JH conceived and designed the research. QC and XJ analyzed data and wrote the manuscript. QC, XD and JZ analyzed data and modified the paper. LZ, XD, JD, YC, and JZ collected patient samples. All authors read and approved the final manuscript.

This work was supported by the Wenzhou Science and Technology Key Problem Program [grant number ZY202004]. The funders had no role in study design; in the collection, analysis, or interpretation of data; in the writing of the manuscript, or in the decision to submit the article for publication.

The datasets of the current study are not publicly available due individual privacy of patients could be involved, are available from the corresponding author on request.

This study was approved by the Institutional Review Board (IRB) of Wenzhou Central Hospital (No. L2020-01-054). Written consent was waived by the IRB as described previously. This study has been approved by the ethics committee of Wenzhou Central Hospital. The data used in this study was anonymised before analysis.

Not applicable.

The authors declare that they have no competing interests to disclose.